The Shotlee Journal
Browse Shotlee articles about Weight Management.
Showing 9 / 869 Weight Management articles
Novo Nordisk India and Emcure Pharma have announced a strategic partnership to launch Poviztra®, a semaglutide injection, in India. This collaboration aims to improve the availability and marketing of semaglutide for weight management across the country.
Actress Tamannaah Bhatia has spoken out about rumors surrounding her weight and addressed her struggles with inflammation. She emphasized the changing nature of a woman's body and the importance of embracing natural curves.
As the effects of weight loss medications like Mounjaro or Wegovy potentially diminish, some may be tempted to explore social media tricks. Discover scientifically-informed strategies to enhance your weight loss journey and overcome plateaus.
This article explores the potential effects of Ozempic on bone health during weight loss. While Ozempic itself may not directly cause bone loss, the weight loss it induces can affect bone density. Learn how to protect your bones with proper nutrition and exercise.
Michael McIntyre recently showcased his weight loss transformation in London, attributing it to the use of Mounjaro. He openly discussed his journey, including initial reluctance and subsequent positive results. He also commented on others using similar methods.
The global market for oral proteins and peptides is experiencing rapid expansion, with projections estimating a value of US$ 47.2 billion by 2035. This growth, driven by increasing demand for peptide-based therapeutics and advancements in delivery technologies, signifies a dynamic shift in the pharmaceutical and nutraceutical landscape.
AstraZeneca has completed the acquisition of SixPeaks Bio, marking a significant step in developing advanced obesity treatments. The deal involves an initial payment of $170 million, with potential milestone payments to follow, focusing on therapies that preserve muscle mass during weight loss.
The GLP-1 weight loss market is experiencing significant shifts with new leadership and competitive pressures. This article dives into the latest developments surrounding semaglutide, Ozempic, and Wegovy, and explores the broader impact on health and wellness.
New data reveals a drop in US obesity rates, and GLP-1 drugs like Ozempic and Wegovy are likely playing a significant role. This post explores the impact of these medications and what it means for your health.
